Monthly Archives: May 2025

Stanecia Graham Joins The Super Patch Company Fueling Global Growth and Drug-Free Sports Movement

The Super Patch Company is thrilled to announce that Stanecia Graham, a celebrated former professional basketball player and multi-million-dollar network marketing leader, has joined the company as both a field builder and as the newly appointed Head of Athlete Relations.
This high-profile addition to the Super Patch leadership team marks a major milestone in the company’s explosive trajectory toward 100% growth in 2025.
Graham’s dual role will see her building and mentoring a dynamic organization of distributors, while also spearheading the company’s global initiative to bring its drug-free, stimulant-free performance patches to athletes across the world.
“Stanecia embodies everything we stand for—resilience, performance, integrity, and innovation,”
said Jay Dhaliwal, Founder and CEO of The Super Patch Company.
“She’s not just joining our movement—she’s helping to lead it. Her experience both on the court and in the field makes her uniquely positioned to help athletes and entrepreneurs tap into their highest potential.”
Graham’s journey from the hardwood to high-level entrepreneurship is nothing short of inspiring. A dominant force in basketball, she became the second all-time leading scorer at Cloud County Community College with 1,182 points, earned Big 12 Player of the Week honors while at Texas Tech University, and was inducted into her college’s Athletic Hall

Read more...

LifeVantage Revenue Q1 2025 Up 21.1% To $58.4 Million

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025.
Third Quarter Fiscal 2025 Summary*:

Revenue was $58.4 million, an increase of 21.1% from the prior year period.
Excluding the negative impact of foreign currency fluctuations, third quarter revenue increased approximately 22.1%;
Revenue in the Americas increased 29.5%, and revenue in Asia/Pacific & Europe decreased 7.2%.
Excluding the negative impact of foreign currency fluctuations, third quarter revenue in Asia/Pacific & Europe decreased approximately 4.7%;
Net income per diluted share was $0.26, versus $0.13 per diluted share a year ago;
Adjusted earnings per diluted share was $0.26, compared to $0.21 a year ago; and
Adjusted EBITDA was $6.4 million compared to $5.1 million a year ago.

* All comparisons are on a year over year basis and compare the third quarter of fiscal 2025 to the third quarter of fiscal 2024, unless otherwise noted.
Steve Fife, President and CEO of LifeVantage said:

“Third quarter results were strong with revenues up 21% year-over-year to $58.4 million, reflecting robust demand for our MindBody GLP-1 System™. We also delivered another quarter of improving profitability including a 210 basis point improvement

Read more...